Not applicableStudy completedNCT04458402What this trial is testingAdjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial CancerWho this might be right forEndometrial Cancer Teresa Meier 8
Early research (Phase 1)Study completedNCT00315861What this trial is testingTopotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesWho this might be right forOvarian CancerEndometrial CancerCervical Cancer+1 more SCRI Development Innovations, LLC 15
Early research (Phase 1)Looking for participantsNCT06400472What this trial is testingSofe-M in Participants With Selected Advanced Solid TumorsWho this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more Eli Lilly and Company 575
Early research (Phase 1)Study completedNCT00523432What this trial is testingA Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic MalignanciesWho this might be right forGenital Neoplasms, Female University of Chicago 15
Not applicableStudy completedNCT01098630What this trial is testingPatient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerWho this might be right forRecurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus Sarcoma+15 more Gynecologic Oncology Group 778
Early research (Phase 1)Looking for participantsNCT05410717What this trial is testingCLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forStage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more Second Affiliated Hospital of Guangzhou Medical University 200
Not applicableUnknownNCT05227898What this trial is testingVirtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With CancerWho this might be right forCancer Blue Note Therapeutics 352
Testing effectiveness (Phase 2)Study completedNCT00064025What this trial is testingMedroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine CorpusWho this might be right forEndometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation+5 more Gynecologic Oncology Group 75
Large-scale testing (Phase 3)Study completedNCT00096408What this trial is testingLaparoscopic Approach to Cancer of the EndometriumWho this might be right forEndometrial Cancer Queensland Centre for Gynaecological Cancer 760
Testing effectiveness (Phase 2)Study completedNCT02755844What this trial is testingSafety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsWho this might be right forRecurrent Endometrial Cancer Hospices Civils de Lyon 35
Early research (Phase 1)Looking for participantsNCT06795009What this trial is testingZanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine CancerWho this might be right forUterine CancerEndometrial Cancer Washington University School of Medicine 36
Large-scale testing (Phase 3)Looking for participantsNCT03422198What this trial is testingShort Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+6 more University of Utah 188
Early research (Phase 1)Active Not RecruitingNCT03120624What this trial is testingVSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial CancerWho this might be right forMetastatic Endometrial CarcinomaRecurrent Endometrial AdenocarcinomaRecurrent Endometrial Carcinoma+7 more Mayo Clinic 34
Early research (Phase 1)UnknownNCT01454479What this trial is testingA Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or CarcinosarcomaWho this might be right forRecurrent Endometrial Cancer Hung-Hsueh Chou 24
Early research (Phase 1)Study completedNCT00423254What this trial is testingSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.Who this might be right forOvarianMelanomaRenal+20 more Mannkind Corporation 12
Testing effectiveness (Phase 2)Study completedNCT01580696What this trial is testingPhase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian CancerWho this might be right forOvarian CancerEndometrial CancerFallopian Cancer+1 more COL George Peoples, MD, FACS 51
Early research (Phase 1)Active Not RecruitingNCT03875820What this trial is testingPhase I Trial of Defactinib and VS-6766.Who this might be right forNSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more Institute of Cancer Research, United Kingdom 87
Early research (Phase 1)Study completedNCT04319757What this trial is testingACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more Acepodia Biotech, Inc. 12
Early research (Phase 1)Study completedNCT01273168What this trial is testingEndoxifen in Adults With Hormone Receptor Positive Solid TumorsWho this might be right forHormone Receptor-Positive BreastGynecologicDesmoid+1 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00703807What this trial is testingStudy of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial CancersWho this might be right forEndometrial Cancer Yale University 10